SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001267602-22-000024
Filing Date
2022-05-12
Accepted
2022-05-12 16:31:33
Documents
77
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q alim-20220331x10q.htm   iXBRL 10-Q 2741774
2 EX-10.11.G alim-20220331xex10_11g.htm EX-10.11.G 88080
3 EX-31.1 alim-20220331xex31_1.htm EX-31.1 20799
4 EX-31.2 alim-20220331xex31_2.htm EX-31.2 21155
5 EX-32.1 alim-20220331xex32_1.htm EX-32.1 16054
  Complete submission text file 0001267602-22-000024.txt   10331210

Data Files

Seq Description Document Type Size
6 EX-101.SCH alim-20220331.xsd EX-101.SCH 49521
7 EX-101.CAL alim-20220331_cal.xml EX-101.CAL 55402
8 EX-101.DEF alim-20220331_def.xml EX-101.DEF 176416
9 EX-101.LAB alim-20220331_lab.xml EX-101.LAB 477820
10 EX-101.PRE alim-20220331_pre.xml EX-101.PRE 351868
71 EXTRACTED XBRL INSTANCE DOCUMENT alim-20220331x10q_htm.xml XML 2308612
Mailing Address 6310 TOWN SQUARE SUITE 400 ALPHARETTA GA 30005
Business Address 6310 TOWN SQUARE SUITE 400 ALPHARETTA GA 30005 678-990-5740
ALIMERA SCIENCES INC (Filer) CIK: 0001267602 (see all company filings)

IRS No.: 200028718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34703 | Film No.: 22918370
SIC: 2834 Pharmaceutical Preparations